Mumbai, : Alkem Laboratories Ltd. has announced an increase in its planned investment to ₹1,036 crore for the expansion of its manufacturing facility in Ujjain, Madhya Pradesh, reinforcing its commitment to strengthening production capacity and supporting long-term growth. The enhanced investment is aimed at scaling up
New Delhi, : In a timely intervention to ease pressure on critical healthcare supply chains, the Government of India has announced customs duty relief measures for the pharmaceutical and medical technology (MedTech) sectors, aiming to address ongoing supply constraints and rising input costs. The move is
New Delhi, April 2, 2026 – The Association of Indian Medical Devices Industry (AiMeD) extends its sincere gratitude to the Government of India, particularly the Ministry of Finance and the Ministry of Commerce & Industry, for the prompt announcement of full customs duty temporary exemption
New Delhi, [Insert Date]: Emphasizing the need to strengthen India’s healthcare manufacturing ecosystem, Union Minister of State for Health and Family Welfare and Chemicals & Fertilisers Anupriya Patel stated that India is actively working towards achieving self-reliance in the medical devices sector, with a strong
New Delhi | March 2026 India’s medical device industry has urged the government to provide urgent financial relief measures, including temporary duty rebates and faster tax refunds, as escalating geopolitical tensions in West Asia continue to drive up input costs and disrupt supply chains. Industry body
Visakhapatnam, September 15, 2025: In a landmark moment for India’s MedTech ecosystem, Dr. Ajay Sood, Principal Scientific Advisor to the Hon’ble Prime Minister of India Shri Narendra Modi, officially released the M.Tech and MBA curriculum of Erba Global MedTech University, Visakhapatnam. The ceremony was graced by
New Delhi, September 2, 2025 – The Association of Diagnostics Manufacturers of India (ADMI) has called upon the Ministry of Commerce & Industry to urgently rationalize the inverted duty structure (IDS) affecting diagnostics kits, reagents, and in-vitro diagnostic (IVD) equipment. ADMI emphasized that the current
